Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma

European Journal of Contraception and Reproductive Health Care

Volumn 16, Issue 6, 2011, Pages 480-487

  Socolov, Demetra ^a   Blidaru, Iolanda ^a   Tamba, Bogdan ^a   Miron, Nora ^a   Boiculese, Lucian ^a   Socolov, Razvan ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Conservative treatment; Higham score; Levonorgestrel releasing intrauterine system; Menorrhagia; Uterine myoma

Indexed keywords

HEMOGLOBIN; LEVONORGESTREL;

ADULT; BLOATING; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONFERENCE PAPER; DEVICE REMOVAL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSMENORRHEA; DYSPAREUNIA; FEMALE; FOLLOW UP; HEADACHE; HEMATOCRIT; HIGHAM SCORE; HUMAN; HYSTERECTOMY; INSOMNIA; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MASTALGIA; MENORRHAGIA; MENSTRUATION; OUTCOME ASSESSMENT; OVARY CYST; PATIENT ATTITUDE; PATIENT SATISFACTION; PELVIS PAIN SYNDROME; PICTORIAL BLOOD ASSESSMENT CHART; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; SPOTTING; TREATMENT FAILURE; TUMOR VOLUME; ULTRASOUND; UTERUS BLEEDING; UTERUS MYOMA; WEIGHT GAIN;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; DEVICE REMOVAL; FEMALE; HUMANS; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICES, MEDICATED; LEIOMYOMA; LEVONORGESTREL; MENORRHAGIA; MIDDLE AGED; ORGAN SIZE; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR BURDEN; UTERINE HEMORRHAGE; UTERINE NEOPLASMS; UTERUS;

EID: 80955126751     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2011.614028     Document Type: Conference Paper

References (26)

1. Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fi broids for abnormal uterine bleeding: Results regarding the degree of intramural extension. Obstet Gynecol 1993;82:736-40. (Pubitemid 23312179)
2. Higham JM, O' Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9. (Pubitemid 20263124)
3. Dueholm M. Perspectives on " A bnormal uterine bleeding-An international agreement on terminologies and definitions " Gynecol Surg 2008;5:81-4. (Pubitemid 351624493)
4. Magalhaes J, Mendes Aldrighi J, Rodrigues de Lima G. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007;75:193-8. (Pubitemid 46237609)
5. Fedele L, Bianchi S, Rafaelli R, e t al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel releasing intrauterine device. Fertil Steril 1997;68: 426-9. (Pubitemid 27412906)
6. Grigorieva V, Chen Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003;79:1194-8. (Pubitemid 36547859)
7. Naki M. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a signifi cant regression in the uterine and leiomyoma volumes. Fertil Steril 2010;94:371-4.
8. Mercorio F, De Simone R, Di Spezio Sardo A, e t al. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception 2003;67:277-80. (Pubitemid 36398511)
9. Barrington JW, Arunkalaivanan AS, Abdel-Fattah M. Comparison between the levonorgestrel-intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol 2003;108:72-4. (Pubitemid 36411853)
10. Crossignani PG, Vercellini P, Mosconi P, e t al. Levonorgestrel releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-63. (Pubitemid 27318844)
11. Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-9. (Pubitemid 32703819)
12. Kittelsen N, Istre O. A randomised study comparing levonorgestrel- releasing intrauterine system (LNG-IUS) and transcervical resection of the endometrium in the treatment of menorrhagia: Preliminary results. Gynaecol Endosc 1998;7:61-5. (Pubitemid 28192747)
13. Reid PC, Virtanen Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fl uid loss, menstrual blood loss and pictorial blood loss assessment charts. Br J Obstet Gynaecol 2005;112:1-5.
14. Henshaw R, Coyle C, Low S, Barry C. A retrospective cohort study comparing microwave endometrial ablation with levonorgestrel-releasing intrauterine device in the management of heavy menstrual bleeding. Aust NZ J Obstet Gynaecol 2002;42:205-9. (Pubitemid 34578382)
15. Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004;104: 1314 - 21. (Pubitemid 40458729)
16. Wildemeersch D, Schacht E. Treatment of menorrhagia with a novel ' frameless ' intrauterine levonorgestrelreleasing drug delivery system: A pilot study. Eur J Contracept Reprod Health Care 2001;6:93-101. (Pubitemid 32735340)
17. Romer T. Prospective comparison study of levonorgestrel IUD versus roller-ball endometrial ablation in the management of refractory recurrent hypermenorrhea. Eur J Obstet Gynecol Reprod Biol 2000;90:27-9. (Pubitemid 30190196)
18. Nagrani R, Bowen-Simpkins P, Barrington JW. Can the levonorgestrel intrauterine system replace the surgical treatment for the management of menorrhagia? Br J Obstet Gynaecol 2002;109:345-7. (Pubitemid 37329310)
19. Xiao B, Wu S-C, Chong J, et al. Therapeutic effects of levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril 2003;79: 963-9. (Pubitemid 36385021)
20. Zsigmond I, Stamatian F, Bondor C. Dispozitivul intrauterine cu levonorgestrel in hemoragiile associate leiomioamelor [Levonorgestrel intrauterine device in leiomyoma associated bleeding]. Obstet Ginecol 2005; 53:145-9 (in Romanian).
21. Ben-Haroush A, Oron G, Yogev Y, e t al. Attitudes of Israeli gynaecologists towards the levonorgestrelreleasing intrauterine system: A questionnaire survey. Eur J Contracept Reprod Health Care 2004;9: 29-33. (Pubitemid 38746367)
22. Lete I, Obispo C, Izaguirre F, e t al. The levonorgestrel intrauterine system (Mirena ® ) for treatment of idiopathic menorrhagia. Eur J Contracept Reprod Health Care 2008;13:231-7.
23. Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrelreleasing intrauterine device. Ann Med 1990;22:85-90.
24. Andersson K, Odlind V, Rybo G. Levonorgestrelreleasing and copper-releasing (Nova T) IUDs during fi ve years of use: A randomized compared trial. Contraception 1994;49:56-72. (Pubitemid 24077388)
25. Robinson GE, Bounds W, Kubba AA, e t al. Functional ovarian cysts associated with levonorgestrel releasing intrauterine devices. Br J Fam Plann 1989;14:131-2. (Pubitemid 19037358)
26. Zapata L, Whitemann MK, Tepper NK, e t al. Intrauterine device use among women with uterine fibroids: A systematic review. Contraception 2010;82:41-55.